<?xml version="1.0" encoding="UTF-8"?>
<p id="par0190">The presence of non-hemolytic activities among bacterial strains as well as in their active compounds is considered as a safety prerequisite prior to consumption or industrial and pharmacological applications [
 <xref rid="bib0310" ref-type="bibr">62</xref>,
 <xref rid="bib0315" ref-type="bibr">63</xref>]. It is noteworthy that any antimicrobial compound needs to be devoid of hemolytic/cytotoxic activity and present results are in accordance with this.
</p>
